Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SPHK1 | Q9NYA1 | 13/20 | 0.48 |
| ▸ | SPHK2 | Q9NRA0 | 7/20 | 0.42 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.41 |
| ▸ | THRB | P10828 | 2/20 | 0.38 |
| ▸ | THRA | P10827 | 1/20 | 0.38 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19722613 | 0.89 | FFAR4 (0.38) | SPHK1SPHK2FFAR4 | |
| SCHEMBL19721964 | 0.87 | SPHK1 (0.51) | SPHK1SPHK2FFAR4THRBTHRA | |
| SCHEMBL19721892 | 0.84 | SPHK1 (0.48) | SPHK1SPHK2FFAR4THRBTHRA | |
| SCHEMBL19722091 | 0.83 | SPHK1 (0.44) | SPHK1SPHK2THRBTHRA | |
| SCHEMBL19722485 | 0.78 | SPHK1 (0.43) | SPHK1SPHK2 | |
| SCHEMBL19722583 | 0.76 | RARB (0.47) | SPHK1SPHK2FFAR4S1PR3 | |
| SCHEMBL19722283 | 0.76 | RARB (0.47) | SPHK1SPHK2FFAR4 | |
| SCHEMBL19722084 | 0.76 | NAAA (0.39) | — | |
| SCHEMBL17995473 | 0.76 | SPHK1 (0.41) | SPHK1SPHK2FFAR4THRB | |
| SCHEMBL19854030 | 0.76 | SPHK1 (0.43) | SPHK1FFAR4THRBTHRAS1PR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170369418-A1 | POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT | JNC CORPORATION (JP) | 2017-12-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170369418-A1 | POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT | SP1, SPIN1, SAV1 | SPHK1 646/4885SPHK2 790/4885FFAR4 2555/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.